Organization · Venture Capital
Beiley BioFund Inc.
Beiley BioFund Inc. is a Taipei-based biotechnology venture capital firm that invests in early-stage biotech companies. The firm focuses on innovative therapeutics and provides long-term capital and market access to support their growth.
Overview
What Beiley BioFund Inc. does
What Beiley BioFund Inc. is
Beiley BioFund Inc. is a Taipei-based biotechnology venture capital firm that invests in early-stage biotech companies. The firm focuses on innovative therapeutics and provides long-term capital and market access to support their growth.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder
- Last reviewed
- April 30, 2026
Official channels
Find Beiley BioFund Inc. elsewhere
Open the official website or a supported primary organization account.
Capability profile
Beiley BioFund Inc. as a funder
Investment thesis
Beiley BioFund Inc. focuses on investing in innovative biotechnology companies, providing long-term capital to support their research and development processes, and guiding them into capital markets.
Focus narrative
Beiley BioFund primarily invests in biotechnology startups with significant potential for technological innovation. The firm emphasizes long-term investments without geographical restrictions, aiming to address unmet needs in the biotechnology and pharmaceutical sectors.
Value beyond capital
Beiley BioFund adds value to its portfolio companies by providing not only financial support but also access to networks and guidance in navigating capital markets. The firm aims to help biotech teams develop impactful treatments and design efficient development strategies to ensure their therapies reach patients.
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Growth Equity
- Regions
- United States · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio companies include: 祥宏健康 (Xianghong Health): Focused on digital health solutions, recently launched Taiwan's first smart AI long-term care demonstration site. 台寶生醫 (Taiwan Bio): Collaborated with Harvard Medical School to develop new therapies for autoimmune diseases. 麗寶新藥 (Libio Pharmaceuticals): Initiated clinical cooperation with Fukushima Medical University for their LIB-101 drug. 吉晟生技 (Jisheng Biotechnology): Plans for a new facility in Miaoli to enhance their supply chain for radiopharmaceuticals. VerImmune: Recognized for its breakthrough immunotherapy at the RESI JPM 2026 Innovator's Pitch Challenge.
Common questions
What to know about Beiley BioFund Inc.
Upseed classifies Beiley BioFund Inc. under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.